21 September 2020 2 Min Read
Illumina agrees to buy cancer-detection start-up Grail for $8bn
Grail, whose list of high-profile investors includes Bill Gates and Jeff Bezos, is developing a blood test that aims to detect multiple cancers
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In